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Imperial Chncer Research Using noninfectious Sendai virus preparations after selective enzymatic digestion of 
either of the two viral envelope glycoproteins, it was possible to study the effect of 
different virion-cell membrane interactions on virus-specific cytotoxic T lymphocyte 
(CTL) induction in vitro. Three different virus preparations having capacity for virus- 
cell fusion, for virus-cell adsorption or lacking the ability to bind to cell membranes, 
were all active in the generation of virus-specific primary and secondary cytotoxic T 
cells, when added to the culture. Investigations on the responder cell requirements 
during CTL induction revealed that activation by addition of virions lacking the 
capacity to bind to cells was sensitive to the depletion of adherent cells. When virions 
with fusion and binding capacity were presented on tumor stimulator cells, different 
requirements with respect to adherent cells were obtained in the primary and second- 
ary CTL response to Sendai virus. The data indicate that different viral antigen-cell 
membrane interactions govern the activation phase and effector phase of antigen- 
primed T cell populations, while sensitization of unprimed cells is dependent on the 
presence of adherent, perhaps antigen-presenting cells. 
1 Introduction 
Virus-specific cytotoxic T cells (CTL) are restricted by the 
major histocompatibility complex (MHC) and specific for the 
sensitizing virus. In order to effect lysis of target cells, both 
antigenic determinants recognized by the CTL, i.e. the H-2 
antigens and the X-antigens of the virus, must be presented as 
integral components of the membrane of the same target cell 
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[ l ,  21. Infectious virus, injected in vivo in order to trigger 
CTL, integrates surface antigens into the cell membranes and 
thus provides a situation identical to that required for the CTL 
effector activity. However, several investigators have recently 
shown that noninfectious viral preparations will induce virus- 
specific CTL in vivo [3-51 and in vitro [ l ,  2, 6-12]. If the 
maturation of virus-specific precursors into CTL is initiated 
only after presentation of viral antigens together with cell 
membrane structures, then the various virus cell membrane 
interactions should play a crucial role in T cell activation. 
This report presents data using preparations of noninfectious, 
P-propiolactone-inactivated Sendai virus (6-PL-SV) which is 
active in virus-cell adsorption and virus-cell fusion. After 
selective proteolytic digestion, we obtained virion prepara- 
tions with defective capacities for interaction with cell mem- 
branes. Virions treated with trypsin retain the capacity to 
adsorb to cells but do not fuse with the cell membrane, while 
those treated with the protease from s t u ~ h ~ ~ o c O c c u s  
aureZ4S lack both the and the fusion capacity* These 
virion preparations enabled us to study the requirements for 
virion-cell membrane interactions during the induction of pri- 
mary and secondary CTL in vitro. The data indicate that acti- 
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vation phase and effector phase of secondary H-Zrestricted 
virus-specific T cells have different requirements for presenta- 
tion of viral antigens on cell membranes. Unprimed spleen cell 
populations have additional requirements for adherent cells 
which seem to be active in antigen processing. 
2 Materials and methods 
2.1 Animals 
DBN2 and BALB/c strain mice (H-zd) were purchased from 
GI. BomholtgArd, Ry, Denmark, or were raised in our own 
breeding facility (DBA/2 HD). Mice were used at 6-10 weeks 
of age. 
2.2 Viruses 
Sendai virus (SV) and Influenza NVictoria virus (H3N2) were 
propagated, titrated, purified and inactivated as described 
[ l ,  13, 141. p-PL-SV (2 mg in 1 ml of the appropriate buffer) 
was digested with proteolytic enzymes as described previously 
[l]. Trypsin treatment [15]: (8 pl, 5 mg/ml-'; TPCK-treated, 
Worthington Biochemical Corp., Freehold, NJ) for 1 h at 
37°C in 0.5% ammonium hydrogencarbonate buffer, pH 8. 
Treatment with V 8 protease from Staphylococcus aureus: 
(50 pl, 1 mg/ml-'; Miles Labs., Kankakee, IL) for 18 h at 
37°C in 50 mM ammonium hydrogencarbonate buffer, pH 8. 
The capacity of the virus preparations to induce target cell 
formation was measured in the cytolysis assay [13]. Hemag- 
glutinin, neuraminidase, hemolytic activities and cell fusion 
were tested as described previously. As reported [l], virus 
preparations treated with trypsin (Try-SV) had hemagglutina- 
tion and neuraminidase activities comparable to p-PL-SV, but 
lacked the fusion and the hemolytic activity (F-). The prepara- 
tion digested with V 8  protease from S. aureus (V8-SA-SV) 
still contained the F glycoprotein, but the hemagglutinin- 
neuraminidase glycoprotein spike was removed from the vir- 
ion (HANA-). 
2.3 Immunizations 
Mice were injected intraperitoneally (i.p.) with 100 hemag- 
glutinin units (HAU) of infectious virus. Three to 10 weeks 
afterwards, spleens were removed and lymphocytes were pre- 
pared for tissue culture. Antiserum to SV was raised in DBAR 
mice by three weekly i.p. injections of 100 HAU SV. Serum 
was obtained 5 days after the final injection and tested by 
hemagglutinin inhibition (titer: 2.5 x lop3) and enzyme-linked 
immunosorbent assay (ELISA) [16] (titer: 3.5 X 
2.4 Media 
Cells were cultured in RPMI 1640 medium with L-glutamine 
(2 mM final concentration), streptomycin and penicillin (50 
units/ml), 2-mercaptoethanol (2 x M) and 10% fetal calf 
serum. 
2.5 Cell cultures 
P815-X2 (H-2d) and Eb (H-2d) tumor cells, which carry non- 
cross-reactive tumor-specific antigens [ 171, were grown in 
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medium at a concentration of 2 x lo5 cells/ml with medium 
change after every 48 h. Mouse spleen cells or lymph node 
cells were suspended in medium at a concentration of 4 x lo6 
cells/ml. Cells were cultured in multi-dish culture trays (FB-24 
Tc, Linbro Chemicals, New Haven, CT) or in plastic tissue 
culture flasks of different sizes. If desired, cells were depleted 
of erythrocytes by lysis in 0.184 M NH4CI or by separation on a 
Ficoll-Hypaque gradient. B cell depletion was achieved 
through nylon wool column passage [18]. Macrophages and 
adherent cells were removed by passage of cells through 
Sephadex G-10 columns. Phagocytic cells in the cultures were 
destroyed by addition of 100 pg silica/ml (kindly provided by 
Dr. Lemke, Institut fur Genetik, Koln, FRG) [19]. 
2.6 51Cr-release assay 
The conditions of the 51Cr-release assay and the calculation of 
data have been described previously [lo]. All values are the 
mean percent specific "Cr release of triplicate wells. The stan- 
dard errors of the means were always less than k 5% and are 
omitted from the figures for clarity. 
3 Results 
3.1 Induction of a SV-specific secondary CTL response with 
different virus preparations 
We were interested in studying the correlation of induction of 
virus-specific CTL with the capacity of virions to interact with 
cells. We have prepared modified Sendai virions, p-PL-SV, 
Try-SV(F-) and V8-SA-SV (HANA-) which differ in the 
functional activities of the surface glycoproteins. p-PL-SV is 
active in virus-cell binding and fusion, the F- preparation only 
attaches and binds while the HANA- preparation does not 
adsorb to cells, due to lack of the HANA glycoprotein. 
I b l  
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Figure 1. Restimulation of sensitized spleen cells with different virus 
preparations. Responder cells used were P 815 cells infected with 100 
HAU SV or 100 HAU influenza A/Victoria/106 cells. Target cells were 
incubated with virus for a period of 4 h before test. Cytolytic activity 
of responder cells on SV-infected P 815 target cells was tested after 5 
days of incubation with: ( C O )  0.2 HAU/ml infectious SV (a) or 
0.1 pg/ml virus protein of the inactivated preparations (0-PL-SV (b), 
V 8-SA-SV (c) and Try-SV (d)). (C.) 2 HAU/ml SV or 1 pglrnl virus 
protein; (A-A) 20 HAUlml SV or 10 pglml virus protein; (V-V) 
cytolytic activity of the responder cells incubated with 20 HAU SV/ml 
or 10 pg/ml virus protein, respectively, on P 815 target cells infected 
with influenza virus. Killer cells and target cells were coincubated for 
4 h. 
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Spleen cells from DBA/2 strain mice, primed four weeks previ- 
ously with 100 HAU of SV, were restimulated in vitro for 6 
days by addition of the various virus preparations to the cul- 
ture and then tested for cytotoxic activity. The results in Fig. l 
show that, as has been reported previously [lo], both infecti- 
ous and p-PL-SV were active in generating secondary 
cytotoxic effector cells. In both cases, the virions are capable 
of fusing with the plasma membrane, and the viral glycopro- 
teins are presented as integral membrane components of cells 
in the culture. 
However, in contrast to the results obtained previously for 
formation of target cells [l],  virions which had been digested 
with trypsin to selectively inactivate the fusion protein (F-) or 
with S .  aureus V 8  protease to remove the hemagglutinin- 
neuraminidase protein (HANA-) were also active in stimulat- 
ing a secondary CTL response. 
Quantitation of the amounts of viral protein required in order 
to generate comparable cytotoxic activity (by calculation of 
lytic units) revealed that trypsin treatment decreased the 
stimulating capacity 2-3-fold and V 8 protease treatment about 
20-fold. In contrast, the fusion activity of Try-SV and the 
hemagglutinin-neuraminidase activities of V 8-SA-SV were 
decreased at least 100-fold [ 11. When these preparations (Try- 
SV, V8-SA-SV) were checked for target cell formation, which 
can be taken as a sensitive indicator for virus-cell fusion 
[l, 131, up to 500-fold excess of the amount of p-PL-SV 
required for target cell formation was tested and found to be 
negative. Therefore, if there was any fusion capacity left in 
these preparations, it had to be more than 500 times less than 
in p-PL-SV (data not shown). 
CTL, generated with all of these viral preparations, were 
specific for SV and did not lyse syngeneic target cells infected 
with influenza A strain viruses (Fig. 1). Furthermore, CTL, 
generated with these preparations, were restricted by the 
MHC and were sensitive to treatment with antiserum to Thy- 
1.2 and complement (data not shown). 
K : T Ratio 
Figure 2. Time course of primary induction of virus-specific CTL with 
different virus preparations. Responder cells (DBA/2/HD normal) 
were incubated with the viral antigens (1 pg/mlfi-PL-SV (a), 10 pg/ml 
V8-SA-SV (b), 10 pgiml Try-SV (c)) for different periods of time, 
followed by washing, resuspension in medium containing 10% anti- 
serum to SV for 30 min, followed again by threefold washing and 
resuspension in antigen-free medium. Incubation time with antigen: 
A, A 1 day, V, V 2 days, ., 03 days, 0, 0 5 days. Effector cells 
generated after 5 days were tested on SV-infected P815 (open sym- 
bols) and uninfected P 815 control (closed symbols) cells. 
3.2 Induction requirements of virus-specific primary 
responses with SV preparations 
In a preceding paper [lo], we have described the conditions of 
the in vitro induction of a primary CTL response to SV. Lym- 
phocytes from mice negative for antibody to SV were sus- 
pended in tissue culture medium supplemented with 0.1 pg/ml 
p-PL-SV, or 1 pgiml V8-SA-SV or 1 pg/ml Try-SV, respec- 
tively. Cells were incubated either over the whole period of 5 
days in medium containing the antigen, or the cells were resus- 
pended after different intervals into antigen-free medium after 
3-fold washing and additional treatment of cells with anti-SV 
virus antibody for 30 min at 37 "C. Using optimal antigen con- 
centrations, all three virus preparations, p-PL-SV, Try-SV and 
V8-SA-SV were active in the generation of a primary CTL 
response after 5 days (Fig. 2). Thus, SV preparations, lacking 
fusion activity or even inactive in cell adsorption, are capable 
of eliciting a primary CTL response to SV. In this experiment, 
the unprimed cell populations of BALB/c mice generated CTL 
with more efficient cytotoxic activity than the SV-primed 
populations from D B N 2  mice in the previous experiment 
(Fig. 1). This is not interpreted to mean that primary 
responses always yield a higher cytotoxic activity. Comparing 
several experiments of primed and unprimed cell populations, 
the average of cytolytic activity generated in primed cell popu- 
lations is superior to that of unprimed spleen cells. 
Although all three virion preparations induced a T cell 
response when incubated together with responder cells for 5 
days, the time course of induction varied. With virions active 
in fusion andlor cell adsorption, a cytotoxic response was gen- 
erated after incubation of responder cells with virus for a 
period as short as 1 h. Removal of antigen by washing or 
incubation with antibody after the initial binding did not inter- 
fere with CTL induction. Incubation with specific antibody 
blocks CTL generation only if the antibody is added before 
virus-cell binding has taken place [lo]. Induction of primary 
CTL with V8-SA-SV, which lacks the HANA glycoprotein 
and cannot bind to cells, seems to occur by a different mechan- 
ism. Removal of unbound antigen from responder cells after 
various intervals of time showed that the duration of antigen 
presence in medium is crucial. The generated cytolytic activity 
increased with the time the antigen was present in the culture 
and reached an equivalent level to those cultures incubated 
with the other preparations only after 5 days. For this, there 
are at least two explanations: (a) the viral antigens in suspen- 
sion are less active inducers of a T cell-mediated response, and 
washing reduces the antigen concentration below a required 
threshold; (b) the unbound antigen is not active in CTL trig- 
gering and requires the presentation on cells within the cul- 
ture. 
3.3 Role of adherent and phagocytic cells in SV-specific CTL 
induction 
In order to investigate the role of putative antigen-presenting 
cells, primary and secondary induction of SV-specific CTL was 
carried out using purified cell populations. T cells were 
enriched by passage of spleen cells through a nylon wool col- 
umn. Depletion of adherent cells from this T cell-enriched 
fraction was achieved by passage of cells through a Sephadex 
G-10 column. Alternatively, the nylon wool column-enriched 
T cells were cultured in vitro with viral antigens in the presence 
of silica which is selectively toxic for phagocytic cells without 
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reducing the viability of lymphocytes in vitro [19]. The final 
experimental protocol combined these techniques, using nylon 
wool-passaged T cells depleted of adherent cells by Sephadex 
G-10 column and incubated with viral antigens in the presence 
of silica. The results are shown in Fig. 3 a and b. Spleen cells 
from primed BALBic mice depleted of B cells responded well 
to p-PL-SV, V8-SA-SV and Try-SV. Similarly, in previous 
experiments carried out to define the Lyt subsets which par- 
ticipate in the generation of SV-specific CTL [lo], no qualita- 
tive differences in the removal of nylon wool-adherent cells on 
CTL generation by the virus preparations was observed. 
Further separation of macrophages by Sephadex G-10 column 
passage, or  inactivation of phagocytic cells by the presence of 
silica, or both methods combined, did not affect the response 
to p-PL-SV and Try-SV. Decreased cytolytic activity was 
observed in the macrophage-depleted or macrophage-inacti- 
vated cultures using V 8-SA-SV preparations as antigen. 
When selected lymphocyte populations from unprimed 
BALBIc mice were tested, significant differences were 
observed. As seen with primed populations, cytotoxic 
responses to p-PL-SV and Try-SV were generated in popula- 
tions enriched for T cells and depleted of phagocytic cells. In 
contrast, T cell populations depleted of phagocytic cells were 
not sensitized by V8-SA-SV. These results support the second 
explanation proposed for the results found with this antigen 
preparation in the time course experiment: viral antigens in 
suspension, which are unable to adsorb and/or fuse to cells, are 
also unable to activate antigen-specific T cells unless adherent 
and/or phagocytic cells are present in the culture. The sugges- 
tion that macrophages are actively involved in the presentation 
of viral antigens is also consistent with our previous data [20]. 
3.4 CTL response to virions on tumor stimulator cells 
We have previously described [I] that Try-SV, after binding to 
P815 tumor cells, does not render these cells susceptible to 
SV-specific T cell-mediated lysis. When added to the culture 
p-PL-sv 
i b l  Icl 
(B) 
I d 1  
medium, both Try-SV and V8-SA-SV were active in CTL 
generation. This suggested that integration of viral proteins 
into membranes was not a prerequisite for T cell activation. 
Because we could not exclude that these antigens are pro- 
cessed differently on spleen cells, we tested P815 tumor cells 
modified by the SV preparations as stimulators. This protocol 
is not readily applicable to V8-SA-SV since the majority of 
these virions without binding capacity were removed from the 
cells by the washing procedure after virus tumor cell incuba- 
tion. The interpretation of results, using P 815 cells incubated 
with Try-SV, is limited by the possibility that due to the 
neuraminidase activity, the virions detach from the P 815 cells 
and are presented on other cells. Since similar constraints 
apply to the P-815-p-PL-SV stimulator cells, it cannot be 
Table 1. Tumor stimulator cells and virus-specific CTL activation 
Stimulator cells') Activity of responder cellsb) on Eb-SV') target 
cells 
SV-sensitized Unprimed 
Tcell-en- adherent T cell-en- adherent 
riched cell-de- riched cell-depleted 
pleted 
P815 3.9") 4.1 3.4 5.5 
P815 fl-PLSV 31.3 19.4 29.8 4.8 
P815 Ty-SV 22.9 15.4 -0.5 5.0 
P815-V 8-SA-SV 3.8 5.0 4.2 4.4 
a) Stimulator cells were prepared by 1 h incubation of 1 x lo6 3000 rd 
irradiated P815 cells with 1 pg p-PL-SV, 10 pg Try-SV or 10 pg 
V 8-SA-SV, followed by washing of cells. 
b) Stimulator : responder ratio was 1 : 2. Effector cells were tested on 
day 6. 
c) Effector : target cell ratio was 20 : 1. Spontaneous release from Eb- 
SV target cells was 12%. 
d) Results are given in % specific release after subtraction of activity 
on non-virus-modified Eb cells. 
p-PL-sv 
A V8-SA -SV Id1 \ 
-1 12.5 K :  T Ratio 12.5 
TRY - SV 
K : T Ratio 
Figure 3. Effect of depletion of ad- 
herent cells and phagocytic ceIls on 
the induction of primary and second- 
ary SV-specific CTL in vitro, using 
different virus preparations. Cell separa- 
tion: (a) nylon wool column (NWC); (b) 
NWC + Sephadex G-10 column; (c) 
NWC + silica; (d) NWC + silica + 
Sephadex G-10 column. Responder 
cells: (A) BALB/c primed with 100 
HAU infectious SV; (B) normal BALBl 
c cells. Target cells: P815 (0); P815-SV 
(0). S: Stimulating antigens were used 
in the concentrations: 1 @/ml @-PL-SV, 
10 @ml V8-SA-SV, 10 pg/ml Try-SV. 
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excluded that these cells may fuse with cells in culture so that 
the antigen may be re-expressed on other cells. 
Despite these limitations, the findings obtained with these 
stimulator cells are clear (Table 1). Virions with fusion and 
with binding capacity are capable of activating antigen-primed 
T cells depleted of adherent cells, while they are completely 
ineffective in the generation of a primary response in vitro 
from adherent cell-depleted, T cell-enriched populations. 
4 Discussion 
Previous results have shown that insertion of SV glycoproteins 
into the target cell membrane is required for effective lysis by 
CTL [ l ,  2, 211. Having investigated the requirements for the 
primary and secondary induction of cytotoxic virus-specific T 
lymphocytes in vitro [lo], we now studied the generation of 
CTL by SV preparations of different functional activities. We 
have used three preparations of noninfectious virus differing 
with respect to their capacity to interact with cells: (a) intact 
virions with virus-cell fusion capacity (p-PL-SV), (b) trypsin- 
treated virions with cell-binding, but no fusion capacity (Try- 
SV(F-)) and (c) V 8  protease-treated virions lacking cell- 
fusion or cell-binding capacity (V 8-SA-SV (HANA-)). When 
virus preparations were added to the culture, which were 
active (p-PL-SV) or inactive in fusion (Try-SV (F-)), they 
could trigger T cells to mount a cytotoxic response even after 
depletion of phagocytic and adherent cells. However, virus 
preparations without the capacity to attach to cells (V8-SA- 
SV(HANA-)) [22-241 lacked the capacity to induce CTL 
unless macrophages were present in the culture. p-PL-SV and 
Try-SV (F-), presented on tumor stimulator cells, were effec- 
tive in activating antigen-primed cells after depletion of adhe- 
rent cells, while adherent cell-depleted unprimed responder 
cell populations failed to respond. 
The fact that the noninfectious SV preparation (p-PL-SV) can 
be used to activate CTL in vitro and in vivo could be explained 
by its virus-cell fusion capacity. This mechanism provides 
integration of envelope proteins into cell membranes creating 
a situation qualitatively similar to cell infection by which the 
nascent antigens are inserted by fusion from within into the 
cell membrane. This result is in accord with the hypothesis 
[9, 121 that activation of H-2-restricted CTL strictly requires 
copresentation of H-2 and the associative neoantigen (in this 
case a viral glycoprotein) as integral membrane components of 
one cell. The hypothesis requires that (a) only antigens which 
fuse actively with cells or (b) only antigens that are actively 
taken up by cells which are active in presentation [25] should 
allow killer cell generation. This would explain the observa- 
tions that noninfectious viruses which do not fuse with cells, 
can induce virus-specific CTL in vivo [3-51 or in vitro in the 
presence of macrophages [8]. 
The mechanism of in vivo presentation of noninfectious viral 
antigens or nonfusing viruses for triggering of the precursors to 
the CTL is difficult to investigate. Published data derived from 
in vitro stimulation of secondary CTL responses indicate that 
noninfectious virus and viral protein can trigger a secondary 
response [6, 8, 11, 121. It has been argued that the primary 
response in vivo and the secondary response in vitro have 
qualitatively and quantitatively different requirements for 
antigen presentation [12]. We have no direct information as to 
the mechanisms of CTL generation in vivo with inactivated 
SV. The argument that the primary and secondary anti-viral 
CTL response differ mainly quantitatively because different 
numbers of virions are integrated into cell membranes [12] 
seems not to apply to the SV model. First, on the basis of 
earlier calculations on the quantitative requirements for target 
cell formation [l, 131 and present data on CTL induction, we 
conclude that both events require similar amounts of viral pro- 
tein. These protein requirements are not substantially changed 
by the inactivation of the fusion capacity. Second, differences 
seen between the primary and secondary CTL response to 
P815 stimulator cells carrying viral antigens were not due to 
surface antigen density. 
Yet, in vitro activation of antigen-primed cells and in vitro 
sensitization of unprimed cells differ qualitatively. Addition of 
the virus preparations had shown that all three were active, 
but the activation was differentially susceptible to adherent 
cell depletion techniques. When we correlated the require- 
ments for adherent cells during CTL induction with the cell 
interaction capacity of the virus preparations, those virions 
with reduced ability to interact actively with cells were found 
to be more dependent on the presence of adherent cells in 
order to act as antigen. So the V 8-SA-SV (HANA-) prepara- 
tion without cell-binding activity [22-24,261, although capable 
of inducing CTL generation, strictly required the presence of 
adherent cells in order to generate a primary response. The 
experiments of Zinkernagel et al. [27] suggested a crucial role 
for macrophages in the selection of H-2 specificity of the 
immune response. Our data similarly suggest a function of 
macrophages or antigen-presenting cells during primary gener- 
ation of CTL. 
This role of adherent cells was even more prominent when the 
antigen was presented on tumor cells. The interpretation of 
the tumor stimulator cell experiments are somewhat limited by 
the various possible ways in which the viral antigens could 
have been presented on other cells in the culture. Unfortu- 
nately, we could not use fixed cells since there is no primary 
response in vitro to this type of stimulator cells [lo]. Still, the 
results obtained so far show that the generation of a primary 
response, using tumor stimulator cells, is susceptible to adhe- 
rent cell depletion even when the viral antigens are integrated 
into the cell membrane. The P 815 cells lack antigens coded for 
by the I region [28], and further experiments are in progress to 
investigate this point. The data indicate that processing by 
antigen-presenting cells cannot be completely explained 
merely by integration of antigens into the membrane of cells 
carrying syngeneic H-2 K and H-2 D region products. 
In spite of the difficulties in interpreting processing during 
sensitization, we were able to compare the requirements of in 
vitro activation of antigen-primed T cells with the conditions 
which allow aggressive interaction of effector-to-target cells. 
Antigen-primed cells were triggered to generate CTL after 
addition of the three preparations to the cell culture, even 
after depletion of adherent and phagocytic cells. These condi- 
tions were not different when 0-PL-SV and Try-SV (F-) were 
bound to (P815) tumor stimulator cells. The same conditions, 
however, i.e. binding of Try-SV (F-) to P 815 cells, are insuffi- 
cient to allow target cell formation, even when a high amount 
of virus is used under long-term incubation conditions. In sum- 
mary, there is evidence of differences of antigen presentation 
for primary sensitization and activation of antigen-primed 
CTL in vitro. Furthermore, reactivation is possible with cell- 
bound antigens and does not require presentation of viral anti- 
gens as integral membrane components. 
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Although in previous experiments, we were able to prepare 
targets with preparations containing only the two viral gly- 
coproteins devoid of the matrix protein [13], we could not 
further subdivide the CTL populations with specificity for 
HANA or F, respectively. There is strong evidence that the 
fusion activity is involved in target cell formation, but this does 
not implicate a function of F as a target antigen. Because of 
the lack of target cells carrying either the HANA or the F 
protein alone, integrated into the cell membrane, we were not 
able to study this question at the effector cell stage. However, 
our results show that virions devoid of the HANA protein will 
induce in vitro generation of primary and secondary specific 
CTL, thus providing evidence of a T cell subpopulation which 
can be specifically triggered by the F protein. On the other 
hand, the experiments with Try-SV (F-) indicate the existence 
of a T cell subpopulation with specificity for the HANA pro- 
tein of SV. The latter experiment needs qualification. 
Although the functional activity of F had been destroyed on 
these virions, the cleaved F glycoprotein is not detached from 
the virus particle. We are not able to exclude the possibility 
that the functionally inactivated cleaved protein is still anti- 
genically active. Until experiments have been carried out using 
virion subunit preparations containing HANA protein exclu- 
sively, the experimental evidence of HANA-specific CTL 
must be considered as preliminary. 
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